Grants and Contributions:
Title:
Development of Pharmaceutical products for Canada.
Agreement Number:
997367
Agreement Value:
$74,800.00
Agreement Date:
Nov 1, 2022 - Jul 31, 2023
Description:
Archis Life Sciences (ALS) plans to develop or acquire products that fulfill unmet medical needs, manage the required development and regulatory approval process, and market those products in Canada.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Winnipeg, Manitoba, CA R3P 2R3
Reference Number:
172-2022-2023-Q3-997367
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
731778080
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days.
Amendment Date
Mar 21, 2023
Recipient's Legal Name:
Archis Lifesciences Inc.
Federal Riding Name:
Winnipeg South Centre
Federal Riding Number:
46014
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254
Amendments: